Ako optimalizovať prisečníky polymorbidity a polyfarmakoterapie
| Název česky | Jak optimalizova průsečíky polymorbidity a polyfarmakoterapie |
|---|---|
| Autoři | |
| Rok publikování | 2015 |
| Druh | Další prezentace na konferencích |
| Fakulta / Pracoviště MU | |
| Citace | |
| Popis | Polypharmacotherapy often justified and is effective in old age depends primarily on co-existing polymorbidity. Although the individual diseases are quite rightly indicated and treated according to EBM (evidence-based medicine), often from the threat of possible pharmacological interactions recede somewhat into the background. Because it can be difficult to detect serious. About polypharmacy is spoken even in the case where the patient is taking and the only one not strictly necessary medicine. To some extent, this notion tends to mark the co-ordination and the unsuitability of therapeutic procedures and measures. Polypharmacy may lead to an exponential increase in the risk of side effects and drug interactions (with 6 or more drugs, the risk of particularly high by WHO). Principles of Geriatric prescription at a superficial glance may seem to give the impression that a similar prescription in younger individuals. For seniors requires an understanding: a clear indication of the drug; knowledge of dosing; potential side reactions (NUL), and drug interactions. When geriatric prescription is necessary to take into account changes in cognitive function, decreased manual dexterity and vice versa rise to the need for social support. Among the principles of prescribing in the elderly will be in addition to technical expertise in the prescription drugs used in particular knowledge of biopsychosocial factors enabling to meet all individual needs of the senior population. |